DEA Extends Pandemic-Era Telehealth Prescription Rules for Controlled Substances Through December 31, 2025

Nov 15, 2024, 10:57 PM

The U.S. Drug Enforcement Administration (DEA), in collaboration with the Department of Health and Human Services (HHS), has extended the pandemic-era telehealth flexibilities for prescribing controlled substances, including ADHD medications and opioids, for another year. This extension, effective through December 31, 2025, delays the decision on how to unwind these policies to the incoming Trump administration. The extension includes telehealth prescriptions for addiction medications, addressing a contentious issue within the healthcare sector.